These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma. Beilstein M; Silberg D Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613 [TBL] [Abstract][Full Text] [Related]
5. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
8. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
9. ROLE OF MICRORNA IN PREDICTING OF ADENOCARCINOMA DEVELOPMENT IN BARRETT’S ESOPHAGUS. Tsitskarava AZ; Zaraiskiy MI; Vasilevskiy DI; Lapshin AS; Popova VF; Smirnov AA; Lyubchenko ME Vestn Khir Im I I Grek; 2016; 175(4):13-4. PubMed ID: 30457256 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. Smith CM; Watson DI; Michael MZ; Hussey DJ World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019 [TBL] [Abstract][Full Text] [Related]
11. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
12. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623 [TBL] [Abstract][Full Text] [Related]
13. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897 [TBL] [Abstract][Full Text] [Related]
14. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus]. Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323 [TBL] [Abstract][Full Text] [Related]
15. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193 [TBL] [Abstract][Full Text] [Related]
16. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. Wang RH World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094 [TBL] [Abstract][Full Text] [Related]
17. Screening and surveillance for complications related to gastroesophageal reflux disease. Spechler SJ Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938 [TBL] [Abstract][Full Text] [Related]
18. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for neoplastic progression in Barrett's esophagus. Wiseman EF; Ang YS World J Gastroenterol; 2011 Aug; 17(32):3672-83. PubMed ID: 21990948 [TBL] [Abstract][Full Text] [Related]
20. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]